Exosomes Committee

Aims & Scope

 The Exosomes Committee strives to:

• Assist in the planning of the annual meeting scientific program and the review of submitted abstracts in the exosomes category.
• Review the status of the extra-cellular vesicle field and compile a list of major scientific issues that must be addressed to advance or enable cellular therapies.
• Publish position papers and engage in scientific discourse as necessary to advance the field.

Selected Publications

• Critical considerations for the development of potency tests for therapeutic applications of mesenchymal stromal cell-derived small extracellular vesicles (Cytotherapy. 2021 May; 23(5):373-380)
  
  
• Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications (Journal of Extracellular Vesicles, 2019 Apr 29; 8:1, 1609206, DOI: 10.1080/20013078.2019.1609206)

The Committee

Co-Chair

Sai-Kiang Lim, PhD
January 2018 - Present

Paracrine Therapeutics Pte Ltd
Singapore

Co-Chair

Bernd Giebel, PhD
January 2018 - Present

University of Duisburg-Essen
Essen, Germany

Members:

Dominique de Kleijn, PhD
UMC Utrecht
Utrecht, Netherlands

Maurizio Muraca, MD, PhD
University of Padova
Padova, Italy

Luis Ortiz, MD
University of Pittsburgh
Pittsburgh, United States

ESP Leadership Development Program
Ornella Parolini, PhD
Professor 
University Cattolica del Sacro Cuore
Rome, Italy

Paul Robbins, PhD
Professor 
University of Minnesota
Minneapolis, USA

Eva Rohde, MD
Paracelsus Medical University
Salzburg, Austria

Shuji Terai, MD, PhD, FAASLD
Niigata University
Niigata, Japan

Tobias Tertel, MSc
Universitätsklinikum Essen
Essen, Germany

Reza Yarani, PhD
Steno Diabetes Center
Copenhagen, Denmark

Daniel Weiss, MD, PhD
University of Vermont
Burlington, United States

ESP Leadership Development Program 
Elani Wiest, MD, PhD
Mayo Clinic
Jacksonville, United States